{"id":6353,"date":"2025-01-26T12:01:07","date_gmt":"2025-01-26T11:01:07","guid":{"rendered":"https:\/\/darkgreen-crane-601020.hostingersite.com\/rek-kulmu\/clinical-trials-regulation-ctr\/"},"modified":"2026-01-13T14:54:07","modified_gmt":"2026-01-13T13:54:07","slug":"clinical-trials-regulation-ctr","status":"publish","type":"page","link":"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/","title":{"rendered":"Clinical Trials Regulation (CTR)"},"content":{"rendered":"<h2>Research ethics review of pharmaceutical clinical trials (CTR)<\/h2>\n<p>The EU regulation <a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32014R0536&amp;from=EN\" target=\"_blank\" rel=\"noopener\">Clinical Trials Regulation 536\/2014, CTR<\/a> entered into force on January 31, 2022. On behalf of the ethics authorities in Norway, REK KULMU carries out the research ethics assessment of applications that fall under CTR. The assessments are made in accordance with general research ethics principles. CTR is the overriding legislation, but the ethical principles described in the Health Research Act will apply matters that are not mentioned in CTR.<\/p>\n<p>We refer to <a href=\"https:\/\/www.dmp.no\/en\/approval-of-medicines\/clinical-trials\" target=\"_blank\" rel=\"noopener\">NoMA\u2019s website<\/a> for more information on clinical trials under CTR.<\/p>\n<p>We recommend using the templates that are published at the European Commission&#8217;s <a href=\"https:\/\/health.ec.europa.eu\/medicinal-products\/eudralex\/eudralex-volume-10_en#set-of-documents-applicable-to-clinical-trials-authorised-under-regulation-eu-no-5362014\">website<\/a>. See further description of the above-mentioned documents under point 3, Part II application (national application).<\/p>\n<p>Note that the version number and date specified in CTIS must be in accordance with the version number and date specified in the respective documents.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Research ethics review of pharmaceutical clinical trials (CTR) The EU regulation Clinical Trials Regulation 536\/2014, CTR entered into force on January 31, 2022. On behalf of the ethics authorities in Norway, REK KULMU carries out the research ethics assessment of applications that fall under CTR. The assessments are made in accordance with general research ethics [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":5868,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_cn_metabox_post_checkbox_dont_send_once":false,"_cn_metabox_post_checkbox_dont_send_ever":false,"inline_featured_image":false,"footnotes":""},"categories":[62],"tags":[],"class_list":["post-6353","page","type-page","status-publish","hentry","category-rek-kulmu-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clinical Trials Regulation (CTR) - Rekportalen<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Trials Regulation (CTR) - Rekportalen\" \/>\n<meta property=\"og:description\" content=\"Research ethics review of pharmaceutical clinical trials (CTR) The EU regulation Clinical Trials Regulation 536\/2014, CTR entered into force on January 31, 2022. On behalf of the ethics authorities in Norway, REK KULMU carries out the research ethics assessment of applications that fall under CTR. The assessments are made in accordance with general research ethics [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/\" \/>\n<meta property=\"og:site_name\" content=\"Rekportalen\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-13T13:54:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rekportalen.no\/wp-content\/uploads\/2025\/07\/rek.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"573\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/rek-kulmu\\\/clinical-trials-regulation-ctr\\\/\",\"url\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/rek-kulmu\\\/clinical-trials-regulation-ctr\\\/\",\"name\":\"Clinical Trials Regulation (CTR) - Rekportalen\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/#website\"},\"datePublished\":\"2025-01-26T11:01:07+00:00\",\"dateModified\":\"2026-01-13T13:54:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/rek-kulmu\\\/clinical-trials-regulation-ctr\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/rekportalen.no\\\/en\\\/rek-kulmu\\\/clinical-trials-regulation-ctr\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/rek-kulmu\\\/clinical-trials-regulation-ctr\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"REK KULMU\",\"item\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/rek-kulmu\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Clinical Trials Regulation (CTR)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/\",\"name\":\"Rekportalen\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/#organization\",\"name\":\"Rekportalen\",\"url\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/rekportalen.no\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/logo_pms.svg\",\"contentUrl\":\"https:\\\/\\\/rekportalen.no\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/logo_pms.svg\",\"width\":100,\"height\":100,\"caption\":\"Rekportalen\"},\"image\":{\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical Trials Regulation (CTR) - Rekportalen","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/","og_locale":"en_US","og_type":"article","og_title":"Clinical Trials Regulation (CTR) - Rekportalen","og_description":"Research ethics review of pharmaceutical clinical trials (CTR) The EU regulation Clinical Trials Regulation 536\/2014, CTR entered into force on January 31, 2022. On behalf of the ethics authorities in Norway, REK KULMU carries out the research ethics assessment of applications that fall under CTR. The assessments are made in accordance with general research ethics [&hellip;]","og_url":"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/","og_site_name":"Rekportalen","article_modified_time":"2026-01-13T13:54:07+00:00","og_image":[{"width":1200,"height":573,"url":"https:\/\/rekportalen.no\/wp-content\/uploads\/2025\/07\/rek.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/","url":"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/","name":"Clinical Trials Regulation (CTR) - Rekportalen","isPartOf":{"@id":"https:\/\/rekportalen.no\/en\/#website"},"datePublished":"2025-01-26T11:01:07+00:00","dateModified":"2026-01-13T13:54:07+00:00","breadcrumb":{"@id":"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/rekportalen.no\/en\/"},{"@type":"ListItem","position":2,"name":"REK KULMU","item":"https:\/\/rekportalen.no\/en\/rek-kulmu\/"},{"@type":"ListItem","position":3,"name":"Clinical Trials Regulation (CTR)"}]},{"@type":"WebSite","@id":"https:\/\/rekportalen.no\/en\/#website","url":"https:\/\/rekportalen.no\/en\/","name":"Rekportalen","description":"","publisher":{"@id":"https:\/\/rekportalen.no\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rekportalen.no\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/rekportalen.no\/en\/#organization","name":"Rekportalen","url":"https:\/\/rekportalen.no\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/rekportalen.no\/en\/#\/schema\/logo\/image\/","url":"https:\/\/rekportalen.no\/wp-content\/uploads\/2025\/01\/logo_pms.svg","contentUrl":"https:\/\/rekportalen.no\/wp-content\/uploads\/2025\/01\/logo_pms.svg","width":100,"height":100,"caption":"Rekportalen"},"image":{"@id":"https:\/\/rekportalen.no\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/pages\/6353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/comments?post=6353"}],"version-history":[{"count":5,"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/pages\/6353\/revisions"}],"predecessor-version":[{"id":7770,"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/pages\/6353\/revisions\/7770"}],"up":[{"embeddable":true,"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/pages\/5868"}],"wp:attachment":[{"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/media?parent=6353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/categories?post=6353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/tags?post=6353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}